Clinical Trial Update: Paper Applicator Acceptability Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial examining paper applicator acceptability for HIV prevention sponsored by CONRAD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 1, Phase 2 | Status: WITHDRAWN